EUS-radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: Is There a Promising Future?

Overview

Journal Endosc Ultrasound

Date 2025 Jan 13

PMID 39802105

Authors

Sahib Singh

Vishnu Charan Suresh Kumar

Douglas G Adler

Affiliations

Soon will be listed here.

References

Rossi G, Petrone M, Healey A, Arcidiacono P . Approaching Small Neuroendocrine Tumors with Radiofrequency Ablation. Diagnostics (Basel). 2023; 13(9). PMC: 10177414. DOI: 10.3390/diagnostics13091561. View

Biermann M, Sundar P, Veeramachaneni H, Chawla S, Patel V, Orr J . . VideoGIE. 2024; 9(1):45-50. PMC: 10793174. DOI: 10.1016/j.vgie.2023.08.007. View

Debraine Z, Borbath I, Deprez P, Bosly F, Maiter D, Furnica R . Long-term clinical and radiological outcomes of endoscopic ultrasound-guided radiofrequency ablation of benign insulinomas. Clin Endocrinol (Oxf). 2023; 101(5):485-490. DOI: 10.1111/cen.14981. View

Lesmana C . Endoscopic loco-regional treatment in controlling pancreatic neuroendocrine tumors (PNETs) behavior: a case series and literature review. Clin J Gastroenterol. 2024; 17(4):754-759. DOI: 10.1007/s12328-024-01959-2. View

Kos-Kudla B, Castano J, Denecke T, Grande E, Kjaer A, Koumarianou A . European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours. J Neuroendocrinol. 2023; 35(12):e13343. DOI: 10.1111/jne.13343. View

Halfdanarson T, Rabe K, Rubin J, Petersen G . Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival. Ann Oncol. 2008; 19(10):1727-33. PMC: 2735065. DOI: 10.1093/annonc/mdn351. View

Dhar J, Samanta J, Nabi Z, Aggarwal M, Facciorusso A, Conti Bellocchi M . Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review. Expert Rev Gastroenterol Hepatol. 2024; 18(1-3):37-53. DOI: 10.1080/17474124.2024.2321938. View

Crino S, Partelli S, Napoleon B, Conti Bellocchi M, Facciorusso A, Salvia R . Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma. Dig Liver Dis. 2023; 55(9):1187-1193. DOI: 10.1016/j.dld.2023.06.021. View

Borrelli de Andreis F, Boskoski I, Mascagni P, Schepis T, Bianchi A, Schinzari G . Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience. Pancreatology. 2023; 23(5):543-549. DOI: 10.1016/j.pan.2023.05.004. View

10.

Napoleon B, Lisotti A, Caillol F, Gasmi M, Ah-Soune P, Belle A . Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study). Gastrointest Endosc. 2023; 98(3):392-399.e1. DOI: 10.1016/j.gie.2023.04.003. View

11.

Karaisz F, Elkelany O, Davies B, Lozanski G, Krishna S . A Review on Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA) of Pancreatic Lesions. Diagnostics (Basel). 2023; 13(3). PMC: 9914142. DOI: 10.3390/diagnostics13030536. View

12.

Armellini E, Facciorusso A, Crino S . Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis. Medicina (Kaunas). 2023; 59(2). PMC: 9963038. DOI: 10.3390/medicina59020359. View

13.

Khoury T, Sbeit W, Napoleon B . Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies. World J Gastroenterol. 2023; 29(1):157-170. PMC: 9850956. DOI: 10.3748/wjg.v29.i1.157. View

14.

Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y . Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol. 2017; 3(10):1335-1342. PMC: 5824320. DOI: 10.1001/jamaoncol.2017.0589. View

15.

Rimbas M, Rizzatti G, Tosoni A, Impagnatiello M, Panzuto F, Larghi A . Small nonfunctional pancreatic neuroendocrine neoplasms: Time for a step-up treatment approach?. Endosc Ultrasound. 2022; 12(1):1-7. PMC: 10134916. DOI: 10.4103/EUS-D-22-00028. View

16.

Khoury T, Sbeit W, Fusaroli P, Campana D, Brighi N, Napoleon B . Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis. Dig Endosc. 2023; 36(4):395-405. DOI: 10.1111/den.14681. View

17.

Crino S, Napoleon B, Facciorusso A, Lakhtakia S, Borbath I, Caillol F . Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma. Clin Gastroenterol Hepatol. 2023; 21(11):2834-2843.e2. DOI: 10.1016/j.cgh.2023.02.022. View

18.

Hofland J, Falconi M, Christ E, Castano J, Faggiano A, Lamarca A . European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes. J Neuroendocrinol. 2023; 35(8):e13318. DOI: 10.1111/jne.13318. View